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CLINICAL SCALES, CRITERIA AND TOOLS
Cross-cultural adaptation to Brazilian 
Portuguese of the Michigan Neuropathy 
Screening Instrument: MNSI-Brazil
Adaptação transcultural para o português brasileiro do Michigan Neuropathy Screening 
Instrument: MNSI-Brasil
Franassis Barbosa de Oliveira1,2,4, Kárenn Klycia Pereira Botelho2, Arthur Rodrigues Bezerra1,3, Diego Igor de 
Oliveira Azevedo1,3, Clarissa Cardoso dos Santos-Couto-Paz1,3, Emerson Fachin-Martins1,3 
Diabetic sensorimotor polyneuropathy (DSPN) affects 
approximately 10% of the subjects newly diagnosed1,2,3 as 
type 2 diabetes and this percentage can increase by dura-
tion, lack of glycemic and cardiovascular complications3,4,5. 
When appropriately treated by restoration of glycemic 
control3, the progression of the DSPN can be delayed and 
the diabetic ulcers and amputations reduced3,6. However, 
the neuropathy is still the major cause of diabetic foot pre-
senting damaged nerve fibers and this secondary complica-
tion affects more than 50% among the subjects diagnosed 
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ABSTRACT 
Since 1994, the University of Michigan Diabetes Research and Training Center proposed an instrument to measure neuropathies not yet 
adapted to use in Brazil. Then, this study aimed to adapt cross-culturally the Michigan Neuropathy Screening Instrument (MNSI) into 
Brazilian Portuguese, verifying its reliability. Thirty diabetic patients were initially evaluated with the adapted version after completed the 
essential steps to accomplish the cross-cultural adaptation. Twenty-two of them completed the procedures to repeat the measured scores 
after day 1 (trial 0). The repeated measurements were tested at days 2 or 3 (trial 1) by another rater (inter-rater reliability) and retested 
at day 20 (trial 2) by one of the attended raters (inter-test reliability). There were not great semantics, linguistics or cultural differences 
between two versions and excellent reliability was confirmed by intra-class correlation coefficient above 0.840. It was concluded that MNSI 
in the Brazilian version is reliable and it is ready to use.
Keywords: diagnosis; monitoring; diabetic neuropathies.
RESUMO
Desde 1994, o Centro de Treinamento e Pesquisa em Diabetes da Universidade de Michigan propôs um instrumento não ainda adaptado 
para uso no Brasil para mensurar neuropatias. O objetivo deste estudo foi adaptar transculturalmente o Michigan Neuropathy Screening 
Instrument (MNSI) para o Português brasileiro, verificando sua confiabilidade. Trinta pacientes diabéticos foram inicialmente avaliados 
pela versão adaptada depois de completados os passos essenciais para finalizar a adaptação transcultural. Vinte e dois deles completaram 
os procedimentos para repetir os escores medidos depois do dia 1 (ensaio 0). As medidas repetidas foram testadas nos dias 2 ou 3 
(ensaio 1) por outro examinador (confiabilidade interexaminador) e retestadas no dia 20 (ensaio 2) por um dos examinadores participantes 
(confiabilidade interteste). Não existiam diferenças semânticas, linguísticas ou culturais entre as duas versões e excelente confiabilidade 
foi confirmada pelo coeficiente de correlação intra-classe acima de 0,840. Conclui-se que o MNSI na versão brasileira é confiável e está 
pronto para uso.
Palavras-chave: diagnóstico; monitoramento; neuropatias diabéticas.
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from long time, despite could be appreciated that DSPN 
does not surspass the 10% hallmark7. 
Different guidelines recommend annual evalutation for 
DSPN and clinical examination of the lower extremities and 
feet in subjects with diabetes, representing a significant bur-
den for basic care services whereas primary prevention1,2,8.
Regularly, the gold standard methods to diagnose 
DSPN, e.g. nerve condution studies, do not are always eas-
ily avalible due the high cost, especially in Brazil7. Given 
that, the Michigan Neuropathy Screening Instrument 
(MNSI) has been described as an alternative low cost 
method by fast application which allows to score, classify 
and diagnose the neuropathy9.
Developed at Michigan Diabetes Research and Training 
Center in the United States, the MNSI aims to screen the 
symmetric diabetic neuropathy from individuals with diabe-
tes mellitus and its reliability and acuracy were discussed in 
previous studies9,10,11, but not for Brazilian population. 
Also available to screen peripheral neuropathy, the Pain 
Quality Assessment Scale (PQAS) were cross-adapted for 
Brazilian Portuguese; however the PQAS was designed to fo-
cus on assessing the quality of the neuropathic pain in can-
cer patients12. Due to the specific approach to DSPN that in-
cludes other issues related to peripheral neuropathy apart 
from neuropathic pain, the MNSI could be considered a bet-
ter scale to be used in the diabetic population.
Given the circumstances and once authorized by the 
MNSI creators, this study aimed to adapt cross-culturally the 
MNSI into Brazilian Portuguese, verifing its reliability.
METHOD
 In order to ensure the quality of the adapted tool, we car-
ried out a cross-sectional study to translate and adapt trans-
culturally the MNSI, called by us MNSI-Brazil. The essen-
tial steps to accomplish our aim was guided by the process 
to adapt transculturally self-report measures published by 
Beaton and collaborators13 in five sequential stages: 1) trans-
lation, 2) synthesis, 3) back translation, 4) expert committee 
review and 5) pretesting, accompanied paralelly by the trans-
versal stage of  submission and appraisal of all written reports 
by developers. 
This guideline refers to international rules established 
to secure the equivalence maintenance between the origi-
nal questionnaire version and the destiny, in this case: the 
Brazilian population. Once finished, the MNSI-Brazil was 
submitted to psychometric testing to verify the inter-rater 
and inter-test reliabilities. 
This study was approved by Fundação de Ensino e 
Pesquisa em Ciências da Saúde (FEPECS) Ethics Committee, 
D.C. (Report 160.752/2012) and all the participants signed a 
term of free and enligthened acceptance and they were in-
formed about the procedures of all the stages in the study. 
The Michigan Neuropathy Screening Instrument
The original version of MNSI was created in the Michigan 
Center for Diabetes Translational Research (MCDTR) and 
the authorization to performe the cross-cultural adaptation 
was given by Pamela A. Campell as requested by e-mail sent 
May 21, 2013 and answered May 22, 2013. 
The instrument is composed by an introduction which 
gives guidance on how to use MNSI, followed by two ap-
plication forms where one of them is self-administered by 
the patient. The first one, the self-administred, has been 
prepared to score the clinical history (history question-
naire) and the second one to score physical assessment. 
Afterward, the individual scores are added up to give a total 
value. Total value larger than 8 suggests a symmetrical pe-
ripheral neuropathy.
Translation
All parts of the original MNSI (including the introduc-
tion) were translated into Brazilian Portuguese by two native 
Brazilian Portuguese speakers who worked independently. 
They were fluent in English language and have different pro-
files and academic education areas (physical therapy and en-
geneering). One of them was the “ingenuous” translator, be-
cause he did not have experience in the health science.  The 
used “ingenuous” strategy obtains a translation which re-
flects the linguistic norms practiced by population without 
be influenced by schoolar formality.
Synthesis
In order to prepare the first Brazilian Portuguese version, 
the authors compared and synthesized the two translations 
by consensus. The two translations were consistent in almost 
its totality. Only three text fragments (words or phrases) cho-
sen by each translator were different, however expressing the 
same meaning from the Brazilian Portuguese lexicon. At the 
end, they were defined by consensual decision made by the 
authors in: 1) “classificação” instead of “triage”, 2) “perguntas 
sobre a sensibilidade de suas pernas e pés instead of questões 
sobre a sensiblidade de suas pernas e pés” e 3) “hálux” instead 
of “dedo grande do pé”.
Back translation
The first Brazilian Portuguese version was back translat-
ed into English by two professional bilingual translators who 
were fluent in Portuguese and English. They did not partici-
pate in the previous stage and did not know the MNSI. 
Following, the two back translated versions were com-
pared with the original MNSI to validate the consistence 
in the translated version which reflected the same original 
meaning. The two back translations were very similar with 
just two differents text fragments. As in the synthesis, by 
consensual decision were defined: 1) “Michigan Neuropathy 
Screening Instrument” instead of “Michigan Neuropathy 
Classification Instrument” and 2) “numb” instead of “asleep”.
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Expert committee review
A committee composed by 3 rehabilitation and health 
specialists, bilingual, was assisted by the first author to 
achieve cross-cultural equivalence and consolidate all the 
versions of the questionnaire and develop what was consid-
ered the prefinal version for field testing. 
Committee’s meetings were regularly performed to seek the 
linguistic equivalence necessary to make the prefinal version13. 
The words julged do not be equivalent by one of the members 
and text adaptations were reviewed and discussed to reach agree-
ment on the preliminary version applied to Brazilian population.
Pretesting
The prefinal version (Appendix 1, 2 and 3) of the MNSI-
Brazil was applied in 30 subjects with diabetes mellitus and 
tested to assure cross-cultural equivalence. During the pre-
testing, we did not find words of which Brazilian attendee 
could not understand. So the MNSI-Brazil final version did 
not change from de prefinal version. 
The 30 subjects presenting clinical diagnosis of type 2 
diabetes mellitus were evaluated by MNSI-Brazil. The sam-
ple was formed by convenience from two health services: 
1) an assistential program called Universidade Aberta à 
Terceira Idade (UNATI) linked to the Universidade Estadual 
de Goiás (UEG) located in Goiânia, Goiás, Brazil and 2) a 
Center Health Service (CHS) called CHS number 3, located 
in the Ceilândia Administrative Area, Distrito Federal, Brazil. 
Participants presenting peripheral or central neurolog-
ical-related illness do not associated with diabetes in the 
medical records (e.g. traumatic injuries, infections, inherited 
causes and exposure to toxins)  and those ones with cogni-
tive problems identified by Mini-Mental State Examination 
(MMSE) were excluded. Depending the scholar level, we con-
sider different scores as MMSE cut-off point as recommend-
ed. The 13, 18 and 26 scores respectively for those not able to 
read and write, for those  attending at least 7 years of schol-
ling and those schooling 8 years or more14,15. In order to give 
general antropometric characteristics of the sample, we in-
cluded information about body composition (body mass in-
dex) and skin color (leucoderm, faioderm and melanoderm). 
The MNSI-Brazil was applied in an acclimatized room where 
the volunteeers were confortably accommodated to aswer the 
questions put by the raters who filled out the instrument. 
They spended the time required and the raters were ori-
ented to take notes from dubious words or unclear answer. 
The time performed to apply the MNSI-Brazil was timed by 
each rater and all participators. At the end, the participants 
were questioned about their difficulties. The pretesting was 
conducted from August 2014 to May 2015. 
Inter-rater and inter-test reliability
A group composed by 22 volunteers among the initial 
sample (n = 30) agreed to take part in the reliability tests.  The 
tests were performed in three times (trial 0, 1 and 2), during 
four different days (day 1, days 2 or 3 and day 20), by two dif-
ferent raters: rater 1 and 2. The 30 initial volunteers complet-
ed the first MNSI-Brazil application oriented by the rater 1. In 
the day 2 or 3, 22 among them repeat the test applied by other 
rater to test the inter-rater reliability. Twenty days after the 
test, the rater 1 retested the 22 volunteers.
The inter-rater reliability was verified during the test 
phase comparing the MNSI-Brazil scores took in the trial 0 
(day 1) and trial 1 (days 2 or 3). The trials 0 and 1 was per-
formed by different raters (they performed blind-indepen-
dent assessments). In turn to verify inter-test reliability, the 
scores obtained in the trial 0 (day 1) were compared to those 
same scores took during trial 2 (day 20) by the rater 1. After 
20 days is few probable to find peripheral nerve degeneration 
with visible clinical evaluation and it is a good period to con-
firme inter-test repeatability16. 
Data processing and statistical analysis
The Shapiro Wilk normality test was used to verify wheth-
er the variables demonstrated the Gaussian distribution and 
it determined the need for parametric tests in the analysis. 
The significance level for all analyses was established at alfa 
equal 0.05. We use descriptive statistic to characterize the 
sample used to reliability tests by mean of average, stand-
art deviation (SD) and frequency distribution (absolut and 
relative).
The Intra-class Correlation Coefficient (ICC) and the 
Limits of Agreement (LOA) were used to define the respec-
tive quality and magnitude of inter-rater and test-retest re-
liability, which were plotted with a 95% confidence interval 
(CI) using the Bland Altman method. ICC values above 0.75, 
between 0.40 and 0.75 and below 0.40 represented excellent, 
moderate and poor reliabilities respectively17. 
RESULTS
Translation and cross-cultural adaptation
We identify few semantic, linguistic or cultural diferences 
during the process of MNSI translation and none serious dis-
crepancies about the vocabulary. Those few divergent words and 
adaptation in the text were elucidated and eliminated by the ex-
pert committee review. The same occurred in the back transla-
tion stage. During the pretesting, all questions were appropriately 
answered and comprehended for the totality of the participants.
During the translation stage, between the versions made 
by the two translators, we do not found divergencies, but 
rather synonym words. Then, this point was solved choosing 
the more common synonymous used by Brazilian people. 
In the same way, the back translation presented few di-
vergencies between the two versions made by each English 
language native translators and the choice was done by the 
terms used in the original version. 
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Reliability tests
The measurement conditions were defined by the raters 
who tested (rater 1 and 2) the volunteers and by the moment 
when the measurements were obtained (test and retest), es-
tablishing two mensurement conditions to test inter-rater 
and inter-test reliabitily.
The participants were 69.05 ± 7.59 years old (mean ± stan-
dard deviation), within the overweight range defined by adult 
Body Mass Index (BMI) classification (28.56 ± 4.05). All par-
ticipants were presenting adequated cognitive status scored 
evaluated by MMSE in 26.55 ± 3.17 and verified during the 
tests by the full comprehension of the self-administered part 
of the MNSI-Brazil. All participants were able to read and 
write (36% attending at least 7 years of scholling and 64% 
schooling 8 years or more).
The sample retested was predominantly female (95%) and 
composed by leucoderm, faioderm and melanoderm people 
as established by Edgard Roquette Pinto who proposed a sys-
tem to classify the three main categories based in the skin 
color and present in the Brazilian population (Table)12. The 
time spent to apply the self-administered part of the MNSI-
Brazil was around three minutes.
The average measured by the MNSI-Brazil in the 3 
measurement conditions (rater 1, rater 2 and retest) was 
4.21 ± 2.09, ranging from 0 to 8 total scores. Just two subjects 
were scored 8 or more defining a diagnosis suggestion of 
DSPN. In the first measurement condition (rater 1) one sub-
ject had been scored 8 (DSPN diagnosis suggestion), however 
the dignosis was not suggested by the rater 2 and in the re-
test. Otherwise, the other subject who was scored 7 by the 
rater 1 was scored 8 by the rater 2 and retested confirming 
the diagnosis suggestion of DSPN.  
The analysis of the inter-rater and inter-test reliability 
(Figure) obtained by the difference (Bland Altman method) 
and ICC values calculated from measurements taken by each 
rater (ICC = 0.840) and in each test (0.864) respectively in-
dicated excellent repeatability17. The Bland Altman plots de-
tected mean differences between raters and tests showing 
small or no significant deviations from zero for most of the 
subjects. In general, the 95% LOA that was obtained between 
the different measures ranged from -2 to 2 points (upper and 
lower graphs in the Figure).
DISCUSSION
To date, none cross-cultural adaptation had been done 
to the MNSI. Then, aside from the newness to introduce a 
Portuguese version of this clinical tool, this study tested the 
reliability of the measuments obtained from this diagno-
sis method in the Brazilian population with diabetes mel-
litus. The cross-cultural adaptation avoids multinational 
and multicultural diversity to uniformize the concepts and 
evaluation aspects desired with losing the principles of the 
diagnosis method. 










































Figure. The bland-altman plots.
Table. Characteristics of the group submitted to reliability tests.
Variables Average or n SD or %
Quantitative
Age (years old) 69.05 ±7.59
BMI 28.56 ±4.05
Mini-mental (score) 26.55 ±3.17
MNSI-Brazil (rater 1) 4.36 ±2.15
MNSI-Brazil (rater 2) 4.22 ±2.24







Group from the total sample (n = 30) 22 100%
Quantitative variables are presented in mean ± standard deviation (SD) and 
qualitative variables are in absolut (n) and relative (%) frequency distribution. 
BMI: Body Mass Index; MNSI: Michigan Neuropathy Screening Instrument.
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In order to make available the instruments created around 
the world, the cross-cultural adaptation of the measurement 
instruments related to human health is essential to use it in 
other countries beyond the country where it was developed 
in a safe and equivalent way to original questionnaire13. 
Nowadays, the DSPN is diagnosed by mean of clinic sig-
nals and information obtained from many complementary 
exams demanding time and procedures to conclude the di-
agnosis. Then, a unique instrument fast and easy-to-apply 
would be helpful in the everyday clinical work. The MNSI-
Brazil can suggest DSPN diagnosis by a set of  clear points in 
the questionnaire and simple physical examination to com-
pose a score system by which we can define objectively if the 
patient may have or not DSPN.
The Portuguese language is spoken by approximately 
240 million of people around the world and the number of 
published articles by Brazilian researchers and Brazilian re-
searcher’s citations has been progressively increased18. 
The MNSI-Brazil version did not need specific transcultur-
al changes in the application forms; however few adaptations 
in the text from the introduction (how to use) had to be made 
to improve the Brazilian Portuguese comprehension. The ac-
tivities demanding in the questionnaire are quite similar be-
tween English and Portuguese as native language people. The 
Brazilian raters affirmed that the MNSI is a simple, fast and 
easy-to-apply test performing it in around three minutes. The 
Brazilian experience confirme the point of view from the spe-
cialists who used the original version of the MNSI9,19,20.
We tested the MNSI-Brazil in a sample composed by pa-
tients who schooling at least 7 years and were able to read 
and write well. This reflected an efficiency to perform the 
self-administered part of the MNSI-Brazil that was observed 
in a maximum of the 3 minutes to respond. Probablely, less 
years of schooling could change the time to perform it; how-
ever we do not have a sample with participants who school-
ing less than 7 years to confirm this hypothesis.
Studies recording electrical activity in the peripheral 
nerve are considered the gold-standard method to detect and 
diagnose the DSPN, even regarding their technical character-
istics to evaluate the nervous fibers function in an accurate 
and precise way. Although electrophysiological studies be the 
best option to diagnose DSPN, they are expensive and, for 
this reason, must not be the initial tool to screening; nerve 
conduction studies must be recommended after the clinical 
approach, by which the MSNI-Brazil can provide additional 
information to the therapeutical decision-taking9,10,11,19.
The MNSI-Brazil reveals that our sample presented few 
signals to conclude a neuropathy diagnosis as observed in 
our results showing just two subjects scored near from the 
minimum to be considered a suggestion of DSPN. Although 
the reliability had demonstrated excellent repeatability, we 
had a sample without patients presenting several suggestion 
of DSPN, once we had recruited them from healthy services 
which were giving care to prevent DSPN. 
The ICC values showed high inter-rater (ICC = 0.840) and 
test-retest (ICC = 0.864) reliabilities which were considered 
excellent21, showing an agreement between measures and 
supporting the use of the MNSI-Brazil for the evaluation of 
patients with diabete mellitus (Figure). The bland-altman 
plots (Figure) allows us to observe a magnitude of error ab-
sent (zero), very close to zero or no more than 2 points for 
inter-rater and test-retest analysis. Psychometrical studies 
pointing to be understandable to find a small error caused 
by sources issued by performance, concentration, learning, 
distraction and others22,23.
At the end, the results showed evidence to support the 
use of the MNSI-Brazil with repeated measures acceptable to 
suggest this instrument among the health professionals deal-
ing with the DSPN in Brazil.
In conclusion, the Brazilian version of Michigan 
Neuropathy Screening Instrument (MNSI-Brazil) did not 
show great semantics, linguistics ou cultural discrepanc-
es or diferences which could suggest any restraints for 
Brazilian people with diabetes mellitus. The translation and 
cross-cultural adaptation process to Portuguese language 
obtained success following the methodological norms sug-
gested and internationally accepted. Excellent reliability and 
internal consistency were found, making the MNSI-Brazil 
a useful instrument to evaluate the peripheral neuropathy 
signs and symptoms in Brazilians with diabetes mellitus. 
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